Article Type
Changed
Mon, 11/05/2018 - 09:22
Display Headline
Aggressive treatment of atherosclerosis: The time is now
Article PDF
Author and Disclosure Information

Gregg C. Fonarow, MD
Director, Ahmanson-UCLA Cardiomyopathy Center, Director Cardiology Fellowship Training Program, Co-Director, UCLA Preventative Cardiology Program, Associate Professor of Medicine, UCLA Division of Cardiology

Address: Gregg C. Fonarow, MD, Division of Cardiology, University of California-Los Angeles, 10833 Le Conte Avenue, Los Angeles, CA 90095; e-mail: [email protected]

The author has indicated that he has received grant and research support from Pfizer, Merck, Bristol-Myers Squibb, and GlaxoSmithKline corporations.

His lecture at The Cleveland Clinic Division of Medicine Grand Rounds was funded in part by an unrestricted educational grant from Pfizer.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the author but are not peer-reviewed.

Issue
Cleveland Clinic Journal of Medicine - 70(5)
Publications
Topics
Page Number
431-434, 437-438, 440
Sections
Author and Disclosure Information

Gregg C. Fonarow, MD
Director, Ahmanson-UCLA Cardiomyopathy Center, Director Cardiology Fellowship Training Program, Co-Director, UCLA Preventative Cardiology Program, Associate Professor of Medicine, UCLA Division of Cardiology

Address: Gregg C. Fonarow, MD, Division of Cardiology, University of California-Los Angeles, 10833 Le Conte Avenue, Los Angeles, CA 90095; e-mail: [email protected]

The author has indicated that he has received grant and research support from Pfizer, Merck, Bristol-Myers Squibb, and GlaxoSmithKline corporations.

His lecture at The Cleveland Clinic Division of Medicine Grand Rounds was funded in part by an unrestricted educational grant from Pfizer.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the author but are not peer-reviewed.

Author and Disclosure Information

Gregg C. Fonarow, MD
Director, Ahmanson-UCLA Cardiomyopathy Center, Director Cardiology Fellowship Training Program, Co-Director, UCLA Preventative Cardiology Program, Associate Professor of Medicine, UCLA Division of Cardiology

Address: Gregg C. Fonarow, MD, Division of Cardiology, University of California-Los Angeles, 10833 Le Conte Avenue, Los Angeles, CA 90095; e-mail: [email protected]

The author has indicated that he has received grant and research support from Pfizer, Merck, Bristol-Myers Squibb, and GlaxoSmithKline corporations.

His lecture at The Cleveland Clinic Division of Medicine Grand Rounds was funded in part by an unrestricted educational grant from Pfizer.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the author but are not peer-reviewed.

Article PDF
Article PDF
Related Articles
Issue
Cleveland Clinic Journal of Medicine - 70(5)
Issue
Cleveland Clinic Journal of Medicine - 70(5)
Page Number
431-434, 437-438, 440
Page Number
431-434, 437-438, 440
Publications
Publications
Topics
Article Type
Display Headline
Aggressive treatment of atherosclerosis: The time is now
Display Headline
Aggressive treatment of atherosclerosis: The time is now
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media